CARDIOVASCULAR
hamburger
BACK
Product Features

CALL TO ORDER PRODUCTS
(855) 478-5833

Product Features

The TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ offers the following features:*

  • Force sensor at the distal catheter tip
  • Fiber optic technology for optimal stability during contact force measurement
  • D, F, and J uni-directional and D-D, D-F, F-F, F-J, and J-J bi-directional deflectable curves
  • Compatibility with steerable sheaths (such as the Agilis™ NxT introducer), resulting in increased contact force1

*Requires TactiSys™ Quartz hardware system and accessories

Unique advantages of the TactiCath Contact Force Ablation Catheter, Sensor Enabled and the TactyiSys Quartz System

Designed for seamless integration, the TactiSys Quartz system is a plug-and-play system that eliminates the need for thermal calibrations.

TactiSys also offers:

  • High-precision contact force measurements with 1 g resolution
  • Real-time feedback: Fast 50 Hz (20 ms) sample rate
  • 2-2-2 electrode spacing for standard electrogram recordings
  • Minimal influence of temperature for stable contact force measurement
  • No impact on the force measurement accuracy from nearby ferrous materials (braiding of sheath, nearby circular mapping catheters)
TactiCath Contact Force Ablation Catheter, Sensor Enabled

Force Time Integral (FTI Index)

The FTI™ index is a clinically validated proprietary index calculating force over time. FTI index is incorporated into the TactiCath Quartz contact force sensing ablation catheter labeling.2

Line graph showing force time interval by ablation duration. FTI equals contact force times time.

Lesion Index (LSI)

The LSI (Lesion Index) is a proprietary index combining contact force, radiofrequency (RF) application duration and RF current. This parameter was designed to model both the resistive heating and thermal conduction stages of lesion formation.

Visual depiction of lesion formation.

References

  1. Mansour, M. (2014, May). TOCCASTAR: Preliminary results of the first prospective randomized study of a contact force sensing ablation catheter for the treatment of paroxysmal AF. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA.
  2. Reddy, V., Shah, D., Kautzner, J., Schmidt, B., Saoudi, N., Herrera, C., … Kuck, K. H. (2012). The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm, 9(11), 1789-1795. http://dx.doi.org/10.1016/j.hrthm.2012.07.016
Indications, Safety & Warnings

MAT-2013026 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

Precautions


Please be sure to read it.

The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.

The information provided here is not intended to provide information to patients and the general public.



Are you a healthcare professional?

 

Test

yesno